Healthcare Pharmaceutical Biotech

Pallas Health NAD+ Nasal Spray vs. Injection: Could This Be the At-Home NAD+ Option You've Been Looking For? Compare the Daily Spray and Weekly Injection

August 15, 2026 12:35 PM

Quick disclosure before you read further: this is a paid advertorial, intended for consumer education about a commercially available product. Where this article uses the word "Investigated," it means this article's own sponsored publishers editorial review of public brand materials - not any external regulatory or legal action. A commission is earned if you purchase through links here. Product claims are attributed to the brand and not...

Read more

BetterMe Rx GLP-1 Review 2026: Is This the GLP-1 Weight-Management Option You’ve Been Looking For? See How the Online Program Works

August 15, 2026 12:05 PM

Quick disclosure before you read further: this content is promotional in nature and is intended for consumer education regarding a commercially available telehealth program. A commission is earned if you purchase through links in this article, and product claims are attributed to BetterMe Rx rather than independently endorsed. BetterMe Rx is a telehealth platform that connects patients with independently licensed providers for evaluation - per...

Read more

LymphoAid Leg Massager Reviews and Complaints 2026: Ready for an Easier Leg-Wellness Routine? Discover the Cordless Compression System

August 14, 2026 8:40 PM

"Reviews and Complaints" means this article's own sponsored publishers review of public pages - not a complaints database or a regulatory record. Disclaimers: this is a paid advertorial for consumer education about a commercially available product, and a commission is earned if you purchase through the links here. Everything attributed to "the brand" below is LymphoAid's own claim, not independently confirmed by this article. LymphoAid markets...

Read more

Revive Therapeutics Reports Grant of Options

August 14, 2026 6:50 PM

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB:RVVTF)(CSE:RVV)(Frankfurt:31R), a life sciences company focused on the research and development of therapeutics for biodefence and pandemic preparedness, today announced the Board of Directors of Revive has authorized the grant of an aggregate of 15,500,000 incentive stock options to key members of our team, including directors, officers, and consultants. The stock options have an...

Read more

FloraNew Reviews & Complaints 2026: Is a Simpler Gut-Wellness Routine What You've Been Looking For? Discover the Once-Daily Formula

August 14, 2026 6:00 PM

Quick disclosure: this is a paid advertorial with affiliate links, intended for consumer education about a commercially available product - a commission is earned if you buy through them. FloraNew is a dietary supplement, not FDA-approved the way a drug would be, and it's not intended to diagnose, treat, cure, or prevent any disease. Brand claims below are FloraNew's own - not independently verified by this publication. Official site:...

Read more

DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of August 7, 2026

August 14, 2026 5:25 PM

DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant delivery of healthcare and monetization of health data by market participants, today announced that its board of directors...

Read more

Avologi Reviews 2026: Is Avologi Good? FDA Records, Customer Experiences, Technology and What Buyers Should Know

August 14, 2026 5:07 PM

Consumers searching "Avologi reviews," "is Avologi good?", "does Avologi work?" or "is Avologi a scam?" will find customer experiences, retailer complaints and brand claims. The best way to assess Avologi is to separate verifiable facts from individual experiences. The short answer: Avologi is a legitimate premium at-home skin-technology brand with specific FDA-cleared Class II devices, hundreds of public customer reviews, defined warranty...

Read more

Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call

August 14, 2026 5:00 PM

Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended June 30, 2026 and will have a conference call to present the Financial Results on August 17, 2026 at 8:30 am Eastern Time. Quarter Ended June 30, 2026...

Read more

75% of US Hospital Finance Leaders Are Reconsidering Medicare Advantage Contracts; 41% Have Acted or Expect a Pullback Within 12 Months

August 14, 2026 12:00 PM

Three in four US hospital finance leaders with material Medicare Advantage exposure say their organizations have already reduced participation, expect to take action within the next 12 months or are actively reevaluating at least one Medicare Advantage payer relationship, according to a Q3 Black Book Research flash poll of 112 hospital and health system finance leaders. Among 104 respondents with material Medicare Advantage exposure, 75.0%...

Read more

Community Health Days Coming to Three Chicago Housing Developments

August 14, 2026 11:50 AM

Families at three Chicago housing developments can receive school physicals, immunizations and health screenings this summer during a series of Community Health Days running through August 16. The events are a partnership between Molina Healthcare of Illinois, the Chicago Housing Authority (CHA), the Chicago Department of Public Health (CDPH) and Prism Health, hosted with each development's Local Advisory Council. Prism Health's Wellness on...

Read more

Youth Within Reviews and Complaints: Ready to Take Your Skin Routine Beyond the Surface? Discover the Inside-Out NAD+ Wellness Approach

August 14, 2026 11:20 AM

Quick disclosure: this is a paid advertorial, and a commission is earned if you buy through the links below. Product claims are attributed to the brand and aren't independently endorsed. Youth Within is marketed as a dietary supplement, not a drug - FDA doesn't approve dietary supplements for safety and effectiveness before they're sold, and the product isn't intended to diagnose, treat, cure, or prevent any disease. This content is promotional...

Read more

New Study From CVS Caremark and Employee Benefit News Shows How Employers Rely on Their Pharmacy Benefit Manager To Create Sustainable Pharmacy Solutions

August 14, 2026 10:50 AM

Originally published on CVS Health Company Newsroom CVS Caremark, part of CVS Health® (NYSE:CVS), announced the findings of a survey conducted in partnership with Employee Benefit News that reveals why employers are increasingly relying on their pharmacy benefit manager (PBM) partners to use their expertise, scale and purchasing power to help them manage their top concern: battling rising drug prices and maintaining access to quality care. This...

Read more

Nearly Two-Thirds of US Hospital Finance Leaders Are Modeling 2027-2028 Workforce Cuts, Clinical Service Reductions or Restructuring

August 14, 2026 9:45 AM

Black Book Research today announced findings from a flash poll of 85 hospital and health system finance executives revealing that nearly two-thirds, 63.5%, are actively modeling workforce reductions, clinical service cuts, site closures or major organizational restructuring in response to enacted or anticipated federal coverage and reimbursement changes. Another 20.0% are modeling capital-project delays, hiring freezes or nonclinical spending...

Read more

Strengthening the Transplant System: 5 Common Myths About Living Kidney Donation

August 14, 2026 9:35 AM

With more than 90,000 people in the U.S. on the national transplant waitlist, the demand for life-saving organs far outpaces the supply. Living donation offers a strong pathway to addressing this public health challenge, and supporting a larger potential donor pool requires providing clarity on perceived barriers in the process. Angela Laino, a DaVita social worker who guides patients through their transplant journeys, recently became a...

Read more

Pallas Health GLP-1 Reviews 2026: Ready to Make Weight Management a Real Priority? Discover the Doctor-Led Online GLP-1 Option

August 14, 2026 9:20 AM

Quick disclosure before you read further: this is a paid advertorial, and a commission is earned if you purchase through links in this article. Pallas Health is a telehealth platform connecting patients with independently licensed clinicians who may prescribe FDA-approved brand-name GLP-1 medications or compounded semaglutide and tirzepatide when clinically appropriate - compounded medications aren't FDA-approved and haven't been reviewed by the...

Read more

TRNR Reports Record Q2 2026 Results, Driven by 445% Revenue Growth; Confirms 2026 Pro Forma Revenue Guidance of More Than $50m and Q4 Profitability

August 14, 2026 9:00 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), owner of the Wattbike, Ergatta, CLMBR and FORME connected fitness brands and pending acquirer of STEPR, today announced financial results for its second quarter ended June 30, 2026. Q2 2026 Financial Highlights Q2 2026 revenue was $6.6 million, a 445% increase compared to Q2 2025. Q2 2026 was the first full quarter of consolidation for Ergatta, which drove a doubling of gross...

Read more

Aptevo Provides 2Q26 Business Update and Reports Second Quarter Financial Results

August 14, 2026 8:05 AM

Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today reported financial results for the quarter ended June 30, 2026 and provided a business update highlighting strong clinical progress for mipletamig, strengthened scientific leadership, non-dilutive funding to advance its solid tumor trispecific...

Read more

CASI Pharmaceuticals Announces First Half 2026 Business and Financial Results

August 14, 2026 6:45 AM

CASI Pharmaceuticals, Inc. (OTCQB:CASIF), a clinical-stage biopharmaceutical company developing CID-103, an anti-CD38 monoclonal antibody, for patients with antibody-mediated rejection (AMR) in organ transplant and various autoimmune diseases, today reported business and financial results for the first half year ended June 30, 2026. "We remained focused on advancing the development of our lead program, CID-103," said Dr. Wei-Wu He, Executive...

Read more

Victory In Motion, Home of Knee Repair, NOT Knee Replacement(R) Launches New Book by Dr. Marc Pietropaoli

August 14, 2026 6:00 AM

Most patients who receive a joint replacement recommendation never hear the word biologic. They are rarely told about regenerative medicine, bone marrow aspirate cell procedures, or healing laser therapy. They are told their arthritis is severe, that conservative care has been exhausted, and that replacement is the next step. Orthopedic surgeon Dr. Marc Pietropaoli has spent the last two decades building a practice premised on the idea that this...

Read more

BetterMe Rx NAD+ Review 2026: Ready to Move Beyond Ordinary Wellness Supplements? Discover the Provider-Reviewed NAD+ Option

August 13, 2026 7:35 PM

Quick disclosure before you read further: this is a paid advertorial. A commission is earned if you purchase through links in this article. Product claims are attributed to the brand and are not independently endorsed. BetterMe Rx NAD+ is a prescription, pharmacy-compounded product available only after a licensed provider determines it is clinically appropriate - it is not FDA-approved, and per the brand's own disclaimer, is not intended to...

Read more